1.38

0.00% 0.00

After Hours: 1.38

Aytu Biopharma Inc (AYTU)

Overview News Price History Financials Why AYTU Down? Discussions Forecast Stock Split

Aytu Biopharma Inc stock is traded at $1.38, with a volume of 26,971. It is up +0.00% in the last 24 hours and down -7.38% over the past month. Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

Previous Close:

$1.38

Open:

$1.44

24h Volume:

26,971

Relative Volume:

0.76

Market Cap:

$8.49M

Revenue:

$93.76M

Net Income/Loss:

$-13.68M

P/E Ratio:

-0.1344

EPS:

-10.27

Net Cash Flow:

$8.77M

1W Performance:

-4.17%

1M Performance:

-7.38%

6M Performance:

-50.71%

1Y Performance:

-51.75%

1-Day Range:

$1.35

$1.44

1-Week Range:

$1.3001

$1.47

52-Week Range:

$1.3001

$3.45

Aytu Biopharma Inc Stock (AYTU) Company Profile

Name

Aytu Biopharma Inc

Sector

Healthcare (1176)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

(720) 437-6580

Address

7900 E. UNION AVENUE, DENVER

Employee

102

Twitter

@aytubioscience

Next Earnings Date

2024-12-13

Latest SEC Filings

AYTU's Discussions on Twitter

Compare AYTU with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AYTU Aytu Biopharma Inc	1.38	8.49M	93.76M	-13.68M	8.77M	-2.63
ZTS Zoetis Inc	164.84	74.37B	9.15B	2.43B	2.31B	5.32
HLN Haleon Plc Adr	9.69	43.81B	14.26B	1.55B	0	0.3383
TAK Takeda Pharmaceutical Co Adr	13.10	41.53B	30.27B	1.93B	3.45B	0.6044
TEVA Teva Pharmaceutical Industries Ltd Adr	22.09	25.03B	16.77B	-959.00M	1.37B	-0.85
VTRS Viatris Inc	12.52	14.94B	15.05B	-883.30M	1.89B	-0.74

Aytu Biopharma Inc Stock (AYTU) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-30-21	Initiated	Cantor Fitzgerald	Overweight
May-29-20	Initiated	H.C. Wainwright	Buy

Aytu Biopharma Inc Stock (AYTU) Latest News

Dec 14, 2024

Aytu BioScience stock hits 52-week low at $1.4 amid market challenges - Investing.com Australia

Dec 14, 2024

Aytu BioScience stock hits 52-week low at $1.4 amid market challenges By Investing.com - Investing.com South Africa

Dec 14, 2024

Dec 06, 2024

Aytu BioPharma Announces Settlement Approval Hearing for Derivative ClaimsOn December 3, 2024, Aytu BioPharma, Inc. (NASDAQ: AYTU), a Delaware corporation, made a significant disclosure regarding the settlement of certain derivative claims in the Wi - Defense World

Dec 06, 2024

Dec 05, 2024

Aytu BioPharma Proposes Settlement in Shareholder Lawsuit - Yahoo Finance

Dec 05, 2024

Dec 03, 2024

Aytu BioPharma Reaches Settlement Agreement in Derivative Action LawsuitKey Details for Shareholders - StockTitan

Dec 03, 2024

Aytu BioPharma Disclosure Notification - AccessWire

Dec 03, 2024

Tesla CEO Elon Musk's $56B pay package rejected by Delaware judge - Yahoo Finance

Dec 03, 2024